Ranked #512 of 8,699 institutional investors
RTW Investments, LP
New York, NY
$9.50B
US stock portfolio at live prices · today −$120.8M (−1.26%)
Live prices, last trade 11:42 AM ET
- Value at quarter end (Q3 2026)
- $9.92B
- Change from Q2 2026
- −$1.79B (−15.29%)
- Positions
- 77 · 12 new, 9 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$714M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesCGON 7.36%ARGX 7.04%PTGX 6.53%INSM 4.74%SYRE 3.70%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| CGON CG Oncology, Inc. | 8,514,590 | $699M | 7.36% | Unchanged |
| ARGX argenx SE | 711,584 | $669M | 7.04% | Added +0% |
| PTGX Protagonist Therapeutics, Inc. | 5,061,175 | $620M | 6.53% | Unchanged |
| INSM Insmed Incorporated | 3,096,545 | $450M | 4.74% | Reduced −36% |
| SYRE Spyre Therapeutics, Inc. | 3,691,791 | $352M | 3.70% | Reduced −13% |
| RDNT RadNet, Inc. | 4,630,697 | $326M | 3.44% | Reduced −4% |
| ERAS Erasca, Inc. | 22,446,754 | $315M | 3.32% | Added +25% |
| TNGX Tango Therapeutics, Inc. | 14,048,477 | $314M | 3.30% | Added +1% |
| ORKA Oruka Therapeutics, Inc. | 3,139,030 | $297M | 3.13% | Unchanged |
| IRTC iRhythm Holdings, Inc. | 3,118,913 | $297M | 3.13% | Added +43% |
| TARS Tarsus Pharmaceuticals, Inc. | 3,484,066 | $262M | 2.75% | Added +4% |
| XNCR Xencor, Inc. | 6,827,461 | $231M | 2.43% | Added +1% |
| RGEN Repligen Corporation | 1,385,398 | $230M | 2.42% | Added +12% |
| ZLAB Zai Lab Limited | 10,350,973 | $215M | 2.26% | Added +57% |
| GH Guardant Health, Inc. | 1,481,033 | $214M | 2.25% | Unchanged |
| CELC Celcuity Inc. | 3,304,903 | $181M | 1.90% | Unchanged |
| NTRA Natera, Inc. | 600,000 | $166M | 1.75% | Reduced −40% |
| REPL Replimune Group, Inc. | 8,491,525 | $162M | 1.71% | Added +15% |
| STOK Stoke Therapeutics, Inc. | 5,623,525 | $154M | 1.62% | Unchanged |
| VRDN Viridian Therapeutics, Inc. | 4,910,126 | $151M | 1.59% | New |
| CYTK Cytokinetics, Incorporated | 2,862,003 | $149M | 1.56% | Unchanged |
| KOD Kodiak Sciences Inc. | 1,487,934 | $147M | 1.55% | Unchanged |
| NBIX Neurocrine Biosciences, Inc. | 942,684 | $145M | 1.52% | Reduced −26% |
| RARE Ultragenyx Pharmaceutical Inc. | 8,529,394 | $142M | 1.50% | Added +9% |
| IMCR Immunocore Holdings plc | 4,869,798 | $130M | 1.37% | Unchanged |
| ACAD Acadia Pharmaceuticals Inc. | 7,144,524 | $126M | 1.33% | Unchanged |
| KLRA Kailera Therapeutics, Inc. | 10,776,820 | $125M | 1.31% | Unchanged |
| MDGL Madrigal Pharmaceuticals, Inc. | 312,817 | $122M | 1.29% | Reduced −84% |
| IMVT Immunovant, Inc. | 3,177,849 | $102M | 1.08% | Unchanged |
| BLTE Belite Bio, Inc | 715,332 | $93.5M | 0.98% | Unchanged |
| PTCT PTC Therapeutics, Inc. | 1,615,819 | $93.4M | 0.98% | Reduced −79% |
| AXGN Axogen, Inc. | 1,659,376 | $92.3M | 0.97% | Added +64% |
| CSTL Castle Biosciences, Inc. | 2,778,335 | $91.2M | 0.96% | Unchanged |
| CMPS COMPASS Pathways plc | 10,948,591 | $88.9M | 0.94% | Added +2% |
| OBIO Orchestra BioMed Holdings, Inc. | 9,556,063 | $64.3M | 0.68% | Unchanged |
| COGT Cogent Biosciences, Inc. | 2,309,021 | $62.8M | 0.66% | Unchanged |
| HNGE Hinge Health, Inc. | 500,000 | $53.5M | 0.56% | Unchanged |
| DHR Danaher Corporation | 230,000 | $51.5M | 0.54% | Unchanged |
| TSHA Taysha Gene Therapies, Inc. | 13,560,258 | $50.7M | 0.53% | Unchanged |
| VSTM Verastem, Inc. | 6,718,081 | $44.8M | 0.47% | Added +1% |
| GPCR Structure Therapeutics Inc. | 2,282,138 | $37.4M | 0.39% | Added +42% |
| SLDB Solid Biosciences Inc. | 5,905,426 | $37.1M | 0.39% | Added +52% |
| RCKT Rocket Pharmaceuticals, Inc. | 17,687,772 | $36.0M | 0.38% | Unchanged |
| NGNE Neurogene Inc. | 1,512,456 | $34.3M | 0.36% | Added +11% |
| KRSA Korsana Biosciences, Inc. | 877,020 | $32.1M | 0.34% | New |
| KYMR Kymera Therapeutics, Inc. | 240,000 | $27.9M | 0.29% | Unchanged |
| AQST Aquestive Therapeutics, Inc. | 7,426,471 | $26.1M | 0.28% | Unchanged |
| AKTS Aktis Oncology, Inc. | 1,592,043 | $26.1M | 0.27% | Unchanged |
| SVRA Savara Inc. | 5,952,380 | $25.3M | 0.27% | Unchanged |
| CGEM Cullinan Therapeutics, Inc. | 2,364,347 | $21.4M | 0.22% | Unchanged |
| DNTH Dianthus Therapeutics, Inc. | 248,063 | $20.9M | 0.22% | Unchanged |
| LRMR Larimar Therapeutics, Inc. | 5,820,891 | $17.5M | 0.18% | Added +127% |
| CADL Candel Therapeutics, Inc. | 3,211,008 | $16.5M | 0.17% | Reduced −50% |
| SLN Silence Therapeutics plc | 700,000 | $13.9M | 0.15% | New |
| BBNX Beta Bionics, Inc. | 998,855 | $13.5M | 0.14% | Reduced −33% |
| BEAM Beam Therapeutics Inc. | 570,394 | $12.2M | 0.13% | Unchanged |
| PYXS Pyxis Oncology, Inc. | 6,506,229 | $11.8M | 0.12% | New |
| SRZN Surrozen, Inc. | 393,560 | $11.6M | 0.12% | New |
| HTFL Heartflow, Inc. | 250,000 | $11.5M | 0.12% | Reduced −15% |
| IPSC Century Therapeutics, Inc. | 8,695,652 | $10.6M | 0.11% | Unchanged |
| LTGO Latigo Biotherapeutics, Inc. | 700,000 | $9.1M | <0.1% | New |
| LMRI Lumexa Imaging Holdings, Inc. | 500,000 | $7.1M | <0.1% | Reduced −23% |
| FRNM Freenome, Inc. | 742,500 | $7.0M | <0.1% | New |
| OCGN Ocugen, Inc. | 6,666,666 | $5.3M | <0.1% | Unchanged |
| DYN Dyne Therapeutics, Inc. | 300,000 | $4.8M | <0.1% | New |
| ADRX ADARx Pharmaceuticals, Inc. | 300,000 | $4.1M | <0.1% | New |
| RGNX REGENXBIO Inc. | 555,555 | $3.9M | <0.1% | New |
| MIST Milestone Pharmaceuticals Inc. | 7,833,336 | $3.0M | <0.1% | Unchanged |
| MDLN Medline Inc. | 70,000 | $2.6M | <0.1% | Unchanged |
| IRON Disc Medicine, Inc. | 30,000 | $2.2M | <0.1% | Unchanged |
| ALLO Allogene Therapeutics, Inc. | 3,250,000 | $2.1M | <0.1% | Unchanged |
| CAPR Capricor Therapeutics, Inc. | 250,000 | $2.0M | <0.1% | Unchanged |
| ABVX ABIVAX Société Anonyme | 26,400 | $1.9M | <0.1% | Unchanged |
| KLRS Kalaris Therapeutics, Inc. | 1,300,000 | $1.7M | <0.1% | Unchanged |
| EVMN Evommune Inc | 208,071 | $1.5M | <0.1% | Reduced −86% |
| OBX Obsidian Therapeutics, Inc. | 67,706 | $810K | <0.1% | New |
| LXEO Lexeo Therapeutics, Inc. | 239,149 | $764K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| DFTX Definium Therapeutics, Inc. | 400,000 | $11.7M |
| IDYA IDEAYA Biosciences, Inc. | 370,370 | $9.6M |
| MAZE Maze Therapeutics, Inc. | 212,000 | $6.8M |
| FDMT 4D Molecular Therapeutics, Inc. | 475,737 | $5.0M |
| WVE Wave Life Sciences, Inc. | 1,350,000 | $3.6M |
| IMA ImageneBio, Inc. | 334,445 | $1.3M |
| AVTX Avalo Therapeutics, Inc. | 175,000 | $1.2M |
| TENX Tenax Therapeutics, Inc. | 696,570 | $885K |
| XGN Exagen Inc. | 195,000 | $724K |